Celebrating the Diversity of Human Brains on Neurodiversity Pride Day: Light Therapy for ADHD and Autism

As Neurodiversity Pride Day approaches on June 16th, we at Neuronic are proud to celebrate and support the diverse range of human brains. Our company is committed to promoting inclusivity and acceptance of individuals with neurodivergent conditions such as ADHD, autism (ASD), OCD, dyslexia, dyspraxia, and Tourette Syndrome (TS).

We believe that everyone has unique strengths, talents, and perspectives that can enrich our communities.

In this blog post, we will explore how light therapy can positively impact neurodivergent individuals, promoting inclusivity and acceptance.

Understanding Neurodiversity and How Light Therapy Can Help

One way that Neuronic aims to contribute to the well-being of neurodivergent individuals is through our light therapy device, the Neuradiant 1070. 

Neurodiversity encompasses the natural variations in brain function and behavior among individuals, including conditions such as ADHD, autism, dyslexia, dyspraxia, and Tourette Syndrome (TS). These individuals possess unique strengths, talents, and perspectives that can enrich our communities, but may also face challenges in communication, social interactions, and sensory sensitivities. 

Light therapy, also known as photobiomodulation, is a cutting-edge approach that uses specific wavelengths of light to stimulate cellular processes in the brain. The good news is that, unlike other therapies, light therapy is non-invasive and drug-free approach!

Research on Light Therapy for Neurodivergent People

 

Light Therapy for ADHD

In a study entitled An open trial of light therapy in adult attention-deficit/hyperactivity disorder, the researchers investigated the potential of morning bright light therapy as a 3-week treatment for 29 adults with attention-deficit/hyperactivity disorder (ADHD) during the fall and winter months. The results showed a significant decrease in ADHD symptoms, improved mood symptoms, and a shift towards earlier sleeping and waking times. This shift was found to be the most important factor in predicting improvement in ADHD symptoms.

Stephan, W. et al. (2022) also found that brain light therapy reduced neuroinflammation, increased cerebral blood flow, reduced oxidative stress, and stimulated neuroplasticity and synaptogenesis in adults with ADHD, which consequently resulted in a greater ability to focus, organize, and manage the symptoms. These findings suggest that tPBM may be a safe and effective treatment option for ADHD.

 

Light Therapy for Autism Spectrum Disorder (ASD)

In a study investigating the effectiveness of low-level laser therapy on 21 children and adolescents on the autistic spectrum (aged 5-17 years), it was found that light therapy was effective in reducing irritability and other associated symptoms and behaviors.

In the study, 40 children and adolescents were evaluated for the effects of low-level laser therapy (LLLT) on symptoms associated with autism spectrum disorder. 21 for these participants received the active treatment, consisting of eight 5-minute procedures administered to specific areas of the skull over a 4-week period. All participants were evaluated using various behavior scales at baseline, week 2, week 4, and week 8.

The study found a statistically significant improvement in the irritability subscale score of the Aberrant Behavior Checklist (ABC) in the test group compared to the placebo group.

Pallanti, S. et al. (2022) also focused on the use of transcranial photobiomodulation (tPBM) over a period of six months for children with Autism Spectrum Disorder (ASD).

The results suggested a reduction in Autism Spectrum Disorder (ASD) severity and cognitive and behavioral rigidity, as well as an increase in sleep quality, improved attention, and a reduction in noncompliant behavior. This also resulted in decreased parental stress.

Because of its high safety, few side effects, and low cost, transcranial photobiomodulation can also be a potential therapy for other neurodivergent conditions, such as dyslexia or Tourette Syndrome, although there is a need for continued clinical research.

Embracing Neurodiversity with Light Therapy

At Neuronic, we are fully committed to supporting individuals with neurodivergent conditions and promoting inclusivity. We are thrilled to see happy neurodivergent customers using our Neuradiant 1070 and getting amazing results through our consultation service, but we also recognize the significant lack of research in this area, especially among adults, or regarding other conditions such as Tourette Syndrome (TS), OCD, dyslexia, dysgraphia, or dyscalculia.

That's why we are dedicated to advancing research on neurological disorders, including neurodevelopment conditions, by pooling our resources and expertise towards this cause. By doing so, we hope to make a positive impact and improve the lives of countless neurodivergent individuals and their families.

As we approach Neurodiversity Pride Day on June 16th, let's come together to embrace and honor the diversity of human brains. At Neuronic, we are proud to offer a light therapy device that may contribute to the well-being of neurodivergent individuals, and we remain committed to supporting the neurodivergent community in any way we can.